Bridgeway Capital Management, LLC Johnson & Johnson Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 150,750 shares of JNJ stock, worth $23.1 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

150,750

Previous 154,897 2.68%

Holding current value

$23.1 Million

Previous $22.6 Million 7.91%

% of portfolio

0.55%

Previous 0.55%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $603,305 - $694,124	-4,147 Reduced 2.68%	150,750 $24.4 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $3.17 Million - $3.46 Million	-21,959 Reduced 12.42%	154,897 $22.6 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $5.52 Million - $5.78 Million	35,546 Added 25.15%	176,856 $28 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $824,096 - $899,260	5,660 Added 4.17%	141,310 $22.1 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $1.36 Million - $1.52 Million	-8,737 Reduced 6.05%	135,650 $21.1 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $14.2 Million - $15.3 Million	92,178 Added 176.56%	144,387 $23.9 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $5.08 Million - $6.06 Million	33,611 Added 180.72%	52,209 $8.09 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.9 Million - $2.13 Million	-11,864 Reduced 38.95%	18,598 $3.29 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $2.44 Million - $2.72 Million	-15,150 Reduced 33.21%	30,462 $4.98 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $1.86 Million - $2.06 Million	-11,050 Reduced 19.5%	45,612 $8.1 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $743,257 - $844,073	-4,700 Reduced 7.66%	56,662 $10 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $202,709 - $224,913	-1,300 Reduced 2.07%	61,362 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $209,950 - $233,311	1,300 Added 2.12%	62,662 $10.1 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $1.16 Million - $1.29 Million	-7,550 Reduced 10.96%	61,362 $10.1 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $12.1 Million - $13.9 Million	-88,300 Reduced 56.17%	68,912 $10.8 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $10.9 Million - $11.9 Million	77,400 Added 96.98%	157,212 $23.4 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $141,691 - $171,061	1,100 Added 1.4%	79,812 $11.2 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $1.56 Million - $2.16 Million	-14,000 Reduced 15.1%	78,712 $10.3 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $757,350 - $869,853	-5,940 Reduced 6.02%	92,712 $13.5 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $1.74 Million - $1.95 Million	13,700 Added 16.13%	98,652 $12.8 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $2.03 Million - $2.23 Million	-15,450 Reduced 15.39%	84,952 $11.8 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $490,308 - $545,181	-3,900 Reduced 3.74%	100,402 $14 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $1.11 Million - $1.33 Million	-9,000 Reduced 7.94%	104,302 $13.5 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $401,214 - $471,504	-3,300 Reduced 2.83%	113,302 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $1.14 Million - $1.26 Million	9,525 Added 8.9%	116,602 $14.1 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $412,830 - $488,861	3,300 Added 3.18%	107,077 $13.7 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $81.9 Million - $89.6 Million	-623,990 Reduced 85.74%	103,777 $14.5 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $94.2 Million - $98.5 Million	727,767	727,767 $94.6 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Johnson & Johnson Transaction History